Affimed N.VのSMA 200
Affimed N.VのSMA 200は何ですか。
Affimed N.V.のSMA 200は$5 -29.70%です。
SMA 200の定義は何ですか。
SMA 200は、過去200日間の終値の非加重平均として計算された過去200日間の平均株価です。
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
NASDAQのセクタHealth CareにおけるSMA 200の企業と比べるAffimed N.V
Affimed N.Vは何をしますか。
affimed (symbol: afmd) is a nasdaq-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. immuno-oncology represents a highly promising approach to cancer treatment that seeks to harness the body’s own immune defenses to attack and destroy tumor cells. natural killer cells, or nk-cells, and t-cells belong to the most potent cells of the human defense arsenal. affimed’s proprietary, next-generation bispecific antibodies, termed tandabs®, are designed to bring nk-cells or t-cells into close proximity to cancer cells that ultimately triggers a signal cascade that leads to the destruction of cancer cells. due to their novel tetravalent tandem architecture, which provides for four binding domains, the tandabs bind to specific targets on immune and cancer cells with high affinity. in addition, tandabs exhibit kinetic properties allowing the administration as regular intravenous infusion and fine-tuning of dosing. affimed beli
Affimed N.Vと類似のsma 200
- CATANA SAのSMA 200は€5 -1.09%です。
- IAMGOLDのSMA 200は$5 +23.50%です。
- CK HutchisonのSMA 200は$5 +7.05%です。
- KBL Merger IVのSMA 200は$5 +0.00%です。
- UnitiのSMA 200はAUD$5 +0.00%です。
- Sensus Healthcare IncのSMA 200は$5 +15.09%です。
- Affimed N.VのSMA 200は$5 -29.70%です。
- Andrew PellerのSMA 200はCAD$5 -4.38%です。
- Hemp NaturalsのSMA 200は$5 +0.00%です。
- Hertsford Capital plcのSMA 200はGBX5 +13.79%です。
- Spir CommunicationのSMA 200は€5 -115.98%です。
- 531のSMA 200は$5 +4.76%です。
- CRH MedicalのSMA 200はCAD$5 -0.20%です。